UnknownPhase 2/3

Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages

Egypt32 participantsStarted 2012-03

Plain-language summary

The study will compare the effect of Aspirin versus clopidogrel effect on uterine perfusion in women with unexplained recurrent pregnancy loss with decreased uterine artery pulsatility index. Null hypothesis: Women with recurrent miscarriage have the same blood flow after aspirin or clopidogrel treatment compared to their uterine artery pulsatility index before treatment.

Who can participate

Age range20 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women aged between 20 to 38 years old. * Regular menstrual cycle (26 to 33 days). * Women with 2 or more previous unexplained first trimester miscarriage. * Impaired uterine perfusion (PI of uterine artery more than 2.5). Exclusion Criteria: * Known hypersensitivity to any of study medication components. * Immunotherapy, endocrinotherapy, anticoagulant or anti-platelet management during the past 3 months

What they're measuring

Improvement in uterine artery pulsatility index

Timeframe: 2 months

Trial details

NCT IDNCT01635426

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-01

Contact for this trial

Mostafa I. Ibrahem, M.D.

00201001955996 mi_monem@yahoo.com

View on ClinicalTrials.gov More Recurrent Pregnancy Loss trials